C07D 515/12
In which the condensed system contains three hetero rings
Official title: in which the condensed system contains three hetero rings
C07D515/12 (In which the condensed system contains three hetero rings) appears on 75 US grants and 111 published applications in this corpus.
Search patents in C07D- Granted patents
- 75
- Published applications
- 111
- Assignees
- 69
- Inventors
- 460
- Latest grant
- 9 Jun 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1986 | 1 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 0 | 0 |
| 1991 | 0 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 1 | 0 |
| 1995 | 0 | 0 |
| 1996 | 0 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 0 | 0 |
| 2001 | 0 | 0 |
| 2002 | 1 | 1 |
| 2003 | 1 | 0 |
| 2004 | 0 | 1 |
| 2005 | 1 | 0 |
| 2006 | 0 | 1 |
| 2007 | 0 | 1 |
| 2008 | 1 | 0 |
| 2009 | 0 | 5 |
| 2010 | 2 | 2 |
| 2011 | 2 | 3 |
| 2012 | 3 | 4 |
| 2013 | 2 | 3 |
| 2014 | 4 | 5 |
| 2015 | 4 | 3 |
| 2016 | 4 | 5 |
| 2017 | 4 | 4 |
| 2018 | 2 | 3 |
| 2019 | 4 | 2 |
| 2020 | 1 | 3 |
| 2021 | 4 | 12 |
| 2022 | 6 | 8 |
| 2023 | 3 | 15 |
| 2024 | 8 | 14 |
| 2025 | 7 | 8 |
| 2026 | 6 | 8 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Macrocyclic compounds, compositions, and methods of using thereof9 Jun 2026US 12,649,750 B2Genzyme Corporation
- Macrocyclic compounds, a process for their preparation and pharmaceutical compositions containing them2 Jun 2026US 12,643,912 B2Les Laboratoires Servier
- Macrocyclic compounds, compositions, and methods of using thereof12 May 2026US 12,624,051 B2Genzyme Corporation
- Modulators of cystic fibrosis transmembrane conductance regulator28 Apr 2026US 12,612,416 B2Vertex Pharmaceuticals Incorporated
- Hybrid cyclic libraries and screens thereof3 Mar 2026US 12,565,518 B2The Johns Hopkins University
- Ras inhibitors1 Oct 2026US 2026/0297112 A1Revolution Medicines, Inc.
- Novel compounds and uses thereof13 Aug 2026US 2026/0234163 A1Acelink Therapeutics, Inc.
- Compounds for treating cancer16 Jul 2026US 2026/0200943 A1Genesis Therapeutics, Inc.
- Macrocyclic heterocycles and uses thereof14 May 2026US 2026/0132133 A1Kumquat Biosciences Inc.
- Ras inhibitors19 Mar 2026US 2026/0078133 A1Revolution Medicines, Inc.
Most cited
By later US patents
- Hybrid cyclic libraries and screens thereof36US 9,250,237 B2The Johns Hopkins University · 2016
- Aryl sultam derivatives as RORc modulators33US 9,115,101 B2Genentech, Inc. · 2015
- Antiviral eudistomins from a marine tunicate24US 4,631,149 AUniversity of Illinois · 1986
- Macrocyclic integrase inhibitors13US 8,497,270 B2Elanco Animal Health Ireland Limited · 2013
- Synthesis of naturally occurring ecteinascidins and related compounds10US 7,795,260 B2Pharma Mar, S. A. · 2010